1Koppenol WH,Bounds PL,Dang CV.Otto Warburg's contributions to current concepts of cancer metabolism[J].Nat Rev Cancer,2011,11(5):325-337.
2Hsu PP,Sabatini DM.Cancer cell metabolism:Warburg and beyond[J].Cell,2008,134(5):703-707.
3Vander Heiden MG,Cantley LC,Thompson CB.Understanding the Warburg effect:the metabolic requirements of cell proliferation[J].Science,2009,324(5930):1029-1033.
4Martinez-Outschoorn UE,Balliet RM,Rivadeneira DB,et al.Oxidative stress in cancer associated fibroblasts drives tumor-stroma co-evolution:A new paradigm for understanding tumor metabolism,the field effect and genomic instability in cancer cells[J].Cell Cycle,2010,9(16):3256-3276.
5Sotgia F,Martinez-Outschoorn UE,Pavlides S,et al.Understanding the Warburg effect and the prognostic value of stromal caveolin-1 as a marker of a lethal tumor microenvironment[J].Breast Cancer Res,2011,13(4):213.
6Chaudhri VK,Salzler GG,Dick SA,et al.Metabolic alterations in lung cancer-associated fibroblasts correlated with increased glycolytic metabolism of the tumor[J].Mol Cancer Res,2013,11(6):579-592.
7Sotgia F,Martinez-Outschoorn UE,Howell A,et al.Caveolin-1 and cancer metabolism in the tumor microenvironment:markers,models,and mechanisms[J].Annu Rev Pathol,2012,7:423-467.
8Pavlides S,Whitaker-Menezes D,Castello-Cros R,et al.The reverse Warburg effect:aerobic glycolysis in cancer associated fibroblasts and the tumor stroma[J].Cell Cycle,2009,8(23):3984-4001.
9Robey IF,Lien AD,Welsh SJ,et al.Hypoxia-inducible factor-1alpha and the glycolytic phenotype in tumors[J].Neoplasia,2005,7(4):324-330.
10Pelicano H,Zhang W,Liu J,et al.Mitochondrial dysfunction in some triple-negative breast cancer cell lines:role of m TOR pathway and therapeutic potential[J].Breast Cancer Res,2014,16(5):434.
